U.S. plans to send 1.5 million doses of AstraZeneca vaccine to Canada, says official: Reuters. cbc.ca/news/politics/…
If this (potential) allotment is doled out on the same per-capita basis as the other shots then Ontario would see about 585,000 of those doses.
That'd be nearly a third of the amount of vaccines that have been distributed by the feds in that province since December. (1.45 million distributed, so far, in Ont.)
This would be more than enough shots to vaccinate every single Ontarian aged 75-79 years of age with one shot (there's roughly 390,000 of them in the province) and it would put a dent in the 70-74 cohort, too (there's roughly 520,000 in this age category.)
Needless to say, the U.S. gift/loan would be a significant boost to the provincial vaccination campaigns.
The U.S. has administered an impressive 116 million doses, so far. 41 million people have been fully vaccinated, according to the latest CDC numbers. covid.cdc.gov/covid-data-tra… While Canada is at 3.5 million doses administered.
White House spokesperson, Jen Psaki, also implied other vaccines may be flowed north: "I will say broadly speaking we also anticipate having additional doses of Moderna, Pfizer, of a range of vaccines, even as we focus on ensuring every adult American has access to the vaccine."
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Vaccine update — based on what we know so far — at least 26.4 million more doses will arrive between April and June. 23 million from Moderna and Pfizer combined, 1.5 million AstraZeneca doses from the Serum Institute and 1.9 million AstraZeneca doses from COVAX.
With the Serum announcement today, Canada will have enough supply to fully vaccinate 3.25 million people by the end of March. (6 million Pfizer and Moderna doses combined, 500,000 Serum-made AstraZeneca.)
All told, the country is projected to have enough supply to fully vaccinate at least 16.45 million people by Canada Day.
The supply will grow once delivery schedules for the AstraZeneca doses are confirmed / if (when?) Johnson & Johnson is approved.
Health Canada found the efficacy of the vaccine to be an estimated 62.1%. The regulator said the clinical trial results "were too limited to allow a reliable estimate of vaccine efficacy in individuals 65 years of age and older."
*But* HC says "efficacy in individuals 65 years of age and older is supported by immunogenicity data, emerging real world evidence and post-market experience in regions where the vaccine has been deployed."
So, the regulator says there's "a potential benefit" for people over 65.
A vaccine update — Pfizer and Moderna told Congress this week they will deliver (a combined) 140 million more doses to the U.S. market over the next five weeks.
If approved this weekend, J&J has said it will distribute at least 20 million single-dose shots by the end of March.
In total, with these three shots, the U.S. will have enough supply to fully vaccinate 90 million more people by April 1. 21.6 million people have already received both doses of either Pfizer or Moderna. At least 111.6 million with antibody protection by the end of the 1st quarter
Canada will have enough vaccines on hand to fully vaccinate 3 million people by the end of March, based on current approvals. J&J and AstraZeneca could get the green light any day now. But, clearly, Canada is lagging.
New — Prime Minister Justin Trudeau has announced plan to produce millions of COVID-19 shots at a plant in Montreal starting this summer, securing a domestic supply of vaccines as the global market contends with delivery delays and protectionist measures.
The National Research Council-owned Royalmount facility will churn out tens of millions of doses of the product developed by Maryland-based Novavax, Trudeau said. That company submitted its vaccine to Health Canada for regulatory approval last Friday.
"This is a major step forward to get vaccines made in Canada, for Canadians ... we need as much domestic capacity for vaccine production as possible," Trudeau said. "We won't rest until every Canadian who wants a vaccine has received one."
New — Trudeau announces Air Canada, WestJet, Sunwing, and Air Transat are cancelling air service to all Caribbean destinations and Mexico starting this Sunday until April 30th.
"They will be making arrangements with their customers who are currently on a trip in these regions to organize their return flights," Trudeau says of the airlines.
"With the challenges we currently face with COVID-19, both here at home and abroad, we all agree that now is just not the time to be flying," Trudeau says.
The COVID-19 vaccine made by Johnson & Johnson is 66 per cent effective in preventing moderate to severe disease — although it was found to be 72 per cent effective in U.S. clinical trials. Canada has ordered 10 million doses — with options for an additional 28 million. #cdnpoli
The vaccine appears to be much less effective against the South African variant — J&J has reported a 57 per cent efficacy rate — which is troubling because that strain has spread to other countries, including the U.S.
The vaccine candidate was 85 per cent effective in preventing severe disease across all regions studied, 28 days after vaccination in all adults 18 years and older.